Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions

Thirlwell, K. L., Colligan, D., Mountford, J. C., Samuel, K., Bailey, L., Cuesta-Gomez, N., Hewit, K. D., Kelly, C. J., West, C. C., McGowan, N. W., Casey, J. J., Graham, G. J., Turner, M. L., Forbes, S. and Campbell, J. D.  Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal…

Read More

Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice

Patel, A., Clementelli, C. M., Jarocha, D., Mosoyan, G., Else, C., Kintali, M., Fong, H., Tong, J., Gordon, R., Gillespie, V., Keyzner, A., Poncz, M., Hoffman, R., Iancu‐Rubin, C.  Pre‐clinical development of a cryopreservable megakaryocytic cell product capable of sustained platelet production in mice.  Transfusion. 2019; 59(12), 3698-3713.  doi: 10.1111/trf.15546

Read More